BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11719832)

  • 1. Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following a very low calorie diet.
    Blaak EE; Glatz JF; Saris WH
    Diabetologia; 2001 Nov; 44(11):2013-7. PubMed ID: 11719832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects.
    Schrauwen P; Schaart G; Saris WH; Slieker LJ; Glatz JF; Vidal H; Blaak EE
    Diabetologia; 2000 Nov; 43(11):1408-16. PubMed ID: 11126411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content.
    Kempen KP; Saris WH; Kuipers H; Glatz JF; Van Der Vusse GJ
    Eur J Clin Invest; 1998 Dec; 28(12):1030-7. PubMed ID: 9893016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.
    Simoneau JA; Veerkamp JH; Turcotte LP; Kelley DE
    FASEB J; 1999 Nov; 13(14):2051-60. PubMed ID: 10544188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
    Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle.
    Cameron-Smith D; Burke LM; Angus DJ; Tunstall RJ; Cox GR; Bonen A; Hawley JA; Hargreaves M
    Am J Clin Nutr; 2003 Feb; 77(2):313-8. PubMed ID: 12540388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
    Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
    Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular transport of fatty acids in muscle. Role of cytoplasmic fatty acid-binding protein.
    Glatz JF; Van Breda E; Van der Vusse GJ
    Adv Exp Med Biol; 1998; 441():207-18. PubMed ID: 9781327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
    Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
    Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
    FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Nordic Diet-Induced Weight Loss Is Accompanied by Changes in Metabolism and AMPK Signaling in Adipose Tissue.
    Fritzen AM; Lundsgaard AM; Jordy AB; Poulsen SK; Stender S; Pilegaard H; Astrup A; Larsen TM; Wojtaszewski JF; Richter EA; Kiens B
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3509-19. PubMed ID: 26126206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.
    Loviscach M; Rehman N; Carter L; Mudaliar S; Mohadeen P; Ciaraldi TP; Veerkamp JH; Henry RR
    Diabetologia; 2000 Mar; 43(3):304-11. PubMed ID: 10768091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different fatty acid chain lengths on fatty acid oxidation-related protein expression levels in rat skeletal muscles.
    Ishizawa R; Masuda K; Sakata S; Nakatani A
    J Oleo Sci; 2015; 64(4):415-21. PubMed ID: 25766930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of resting energy expenditure after weight loss in premenopausal women: potential benefits of a high-protein, reduced-calorie diet.
    Pasiakos SM; Mettel JB; West K; Lofgren IE; Fernandez ML; Koo SI; Rodriguez NR
    Metabolism; 2008 Apr; 57(4):458-64. PubMed ID: 18328345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
    Corpeleijn E; Saris WH; Blaak EE
    Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.
    Corpeleijn E; Mensink M; Kooi ME; Roekaerts PM; Saris WH; Blaak EE
    Obesity (Silver Spring); 2008 May; 16(5):1025-32. PubMed ID: 18309299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation.
    Bezaire V; Spriet LL; Campbell S; Sabet N; Gerrits M; Bonen A; Harper ME
    FASEB J; 2005 Jun; 19(8):977-9. PubMed ID: 15814607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.